Evidence for New Endothelial Cell Binding Sites on Fibrinogen

Summary

In vitro assays were used to characterize adhesion of human aortic, microvascular and umbilical vein endothelial cells to various forms of immobilized fibrinogen. All three types of endothelial cells adhered to fibrinogen in a manner that was independent of the Aα-chain 572-574 RGD cell binding site. In fact, all three adhered to a fragment of the molecule which is composed of only one D domain (D1) of fibrinogen. A time course study revealed that extensive adhesion of endothelial cells on the ligand coated surface occurred between one and two hours incubation. The anti-fibrinogen γA-chain monoclonal antibody 4A5 as well as 4A5 Fabs, blocked adhesion of endothelial cells to fibrinogen, not vitronectin. The inhibitory effects of 4A5 seemed to be indirect because the endothelial cells adhered to the recombinant fibrinogen γ407 (which lacks the γ-chain AGDV sequence of the carboxyl terminal 4A5 binding site) as well as they did to normal recombinant fibrinogen. A recombinant fibrinogen lacking the γ-chain AGDV sequence, containing RGE in place of RGD at the γ-chain 572-574 and 95-97 positions, also supported endothelial cell adhesion. The anti-α_vβ₃ antibody, LM609, blocked adhesion of endothelial cells to fibrinogen. The peptide GRGDSP inhibited endothelial cell adhesion on fibrinogen and vitronectin. These results demonstrate that α_vβ₃ mediated adhesion (attachment and spreading) of HUVECs to fibrinogen may use a site in the D domain of fibrinogen and is not dependent on the Aα-chain RGD (95-97 and 572-574) sequences, as has been shown in shorter term (where cells were rounded) experiments, or the γA-chain 408-411 cell binding sites. Thus, the data reveal the existence of another unidentified site(s) on fibrinogen which can support the irreversible adhesion (attachment and spreading) of endothelial cells.

Key words

Fibrinogen - HUVECs - adhesion - α_vβ₃ - RGD

• References

• 1 Montesano R, Pepper MS, Vassalli JD, Orci L. Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors. J Cell Physiol 1987; 132: 509-16.
• 2 Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta A qualitative assay of angiogenesis in vitro. Lab Invest 1990; 63: 115-22.
• 3 Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin α_vβ₃ for angiogenesis. Science 1994; 264: 569-71.
• 4 Dejana E, Lanquino LR, Polentarutti N, Balconi G, Ryckewaert JJ, Larrieu MJ, Donati MB, Mantovani A, Marguerie G. Interaction between fibrinogen and cultured endothelial cells. J Clin Invest 1985; 75: 11-18.
• 5 Kadish JL, Butterfield CE, Folkman J. The effect of fibrin on cultured vascular endothelial cells. Tissue Cell 11979; 01: 99-108.
• 6 Nicosia RF, Tchao R, Leighton J. Histotypic angiogenesis in vitro: Light microscopic, ultrastructural, and radioautographic studies. In Vitro 1982; 18: 538-49.
• 7 Brighton CT, Albelda SM. Identification of Integrin Cell-Substratum Adhesion Receptors on Cultured Rat Bone Cells J Orthop Res. 1992; 10: 766-73.
• 8 Chang Mei-Chi, Wang Bih-Ru, Huang Tur-Fu. Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by arg-gly-asp-containing peptides. Thromb Haemost 1995; 74: 764-9.
• 9 Mills D, Karpatkin S. Heterogeneity of human fibrinogen: Possible relation to proteolysis by thrombin and plasmin as studied by SDS-polyacrylamide gel electrophoresis. Biochem Biophys Res Commun 1970; 40: 206-11.
• 10 Mosesson MW, Galanakis DK, Finlayson JF. Comparison of human plasma fibrinogen subfractions and early plasmic fibrinogen derivatives. J Biol Chem 1974; 249: 4656-64.
• 11 Smith EB, Slater RS, Hunter JA. Quantitative studies on fibrinogen and low-density lipoprotein in human aortic intima. Atherosclerosis 1973; 18: 479-87.
• 12 Copley AL. The endo-endothelial fibrin lining. A historical account. Thromb Res 1983; (V): 1-26.
• 13 McKee PA, Rogers LA, Marler E, Hill RL. The subunit polypeptides of human fibrinogen. Arch Biochem Biophys 1966; 116: 271-9.
• 14 Doolittle RF, Watt KWK, Cottrell BA, Strong DD, Riley M. The amino acid sequence of the α-chain of human fibrinogen. Nature 1979; 280: 464-8.
• 15 Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984; 309: 30-3.
• 16 Gartner TK, Bennett JS. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem 1985; 260: 11891-4.
• 17 Lottspeich F, Henschen A. Amino acid sequence of human fibrin Preliminary note on the completion of the gamma-chain sequence. Hoppe-Seylers Z Physiol Chem 1977; 358: 935-8.
• 18 Kloczewiak M, Timmons S, Lukas TJ, Hawiger J. Platelet receptor recognition site on human fibrinogen Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain. Biochem 1984; 23: 1767-74.
• 19 D’Souza SE, Ginsberg MH, Plow EF. Arginyl-glycyl-aspartic acid (RGD): A cell adhesion motif. Trends Biochem Sci 1991; 16: 246-50.
• 20 Doolittle RF, Goldbaum DM, Doolittle LR. Designation of sequences involved in the “coiled-coil” interdomainal connections in fibrinogen: construction of an atomic scale model. J Mol Biol 1978; 120: 311-25.
• 21 Ugarova TP, Budzynski AZ, Shattil SJ, Ruggeri ZM, Ginsberg MH, Plow FP. Conformational changes in fibrinogen elicited by its interaction with platelet membrane glycoprotein gpIIb-IIIa. J Biol Chem 1993; 268: 21080-7.
• 22 Thiagarajan P, Rippon AJ, Farrell DH. Alternative adhesion sites in human fibrinogen for vascular endothelial cells. Biochem 1996; 35: 4169-75.
• 23 Cheresh DA. Human endothelial cells synthesize and express an arg-glyasp-directed adhesion receptor invovled in attachment to fibrinogen and von willebrand factor. Proc Natl Acad Sci 1987; 84: 6471-5.
• 24 Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 1989; 58: 945-53.
• 25 Finlayson JS, Mosesson MW. Heterogeneity of human fibrinogen. Biochem 1963; 02: 42-6.
• 26 Kirschbaum NE, Mosesson MW, Amrani DL. Characterization of the γ chain platelet binding site on fibrinogen fragment D. Blood 1992; 79: 2643-8.
• 27 Mosesson MW, Finlayson JS. Subfractions of human fibrinogen; preparation and analysis. J Lab Clin Med 1963; 62: 663-74.
• 28 Pandya BV, Budzynski AZ. Anticoagulant proteases from western diamondback rattlesnake (Crotalus atrox) venom. Biochem 1984; 23: 460-70.
• 29 Pandya BV, Cierniewski CS, Budzynski AZ. Conservation of human fibrinogen conformation after cleavage of the Bβ chain NH₂ terminus. J Biol Chem 1985; 260: 2994-3000.
• 30 Pandya BV, Gabriel JL, O’Brien J, Budzynski AZ. Polymerization site in the β chain of fibrin: mapping of the Bβ1-55 sequence. Biochem 1991; 30: 162-8.
• 31 Siebenlist KR, Meh DA, Mosesson MW. Plasma factor XIII binds specifically to fibrinogen molecules containing g’ chains. Biochem 1996; 35: 10448-53.
• 32 Rooney MM, Parise LV, Lord ST. Dissecting clot retraction and platelet aggregation. J Biol Chem 1996; 271: 8553-5.
• 33 Rooney MR, Farrell DH, van Hemel BM, de Groot PG, Lord ST. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction. Blood 1998; 92: 2374-81.
• 34 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
• 35 Binnie CG, Hettasch JM, Strickland ES, Lord ST. Characterization of purified recombinant fibrinogen: partial phosphorylation of fibrinopeptide A. Biochem 1993; 32: 107-13.
• 36 Taubenfeld SM, Song Y, Sheng D, Ball EL, Matsueda GR. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin. Thromb Haemost 1995; 74: 923-7.
• 37 Gartner TK, Amrani DR, Derrick JM, Kirschbaum NE, Matsueda GR, Taylor DB. Characterization of adhesion of “resting” and stimulated platelets to fibrinogen and its fragments. Thromb Res 1993; 71: 47-60.
• 38 Coller BS. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J Clin Invest 1985; 76: 101-3.
• 39 Charo IF, Fitzgerald LA, Stainer Jr. B, Rall SC, Bekeart LS, Phillips DR Platelet glycoproteins IIb and IIIa: Evidence for a family of immunologically and structurally related glycoproteins in mammalian cells. Proc Natl Acad Sci USA 1986; 83: 8351-6.
• 40 Bennett JS, Hoxie JA, Leitman SF, Valaire G, Cines DB. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody Proc Natl Acad Sci USA. 1983; 80: 2412-7.
• 41 Newman PJ, Allen RW, Kahn RA, Kunicki TJ. Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3. Blood 1985; 65: 227-32.
• 42 Bennett JS, Shattil SJ, Power JW, Gartner TK. Interaction of fibrinogen with its platelet receptor. J Biol Chem 1988; 263: 12948-53.
• 43 Peerschke EIB, Galanakis DK. The synthetic RGDS peptide inhibits the binding of fibrinogen lacking intact α chain carboxyterminal sequences to human blood platelets. Blood 1987; 69: 950-2.
• 44 Farrell DH, Thiagarajan P, Chung DW, Davie EW. Role of fibrinogen α and γ chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992; 89: 10729-32.
• 45 Plow EF, Pierschbacher MD, Ruoslahti E, Marguerie GA, Ginsberg MH. The effect of arg-gly-asp-containing peptides on fibrinogen and von willebrand factor binding to platelets. Proc Natl Acad Sci USA 1985; 82: 8057-61.
• 46 Lam SC-T, Plow EF, Smith MA, Andrieux A, Ryckwaert J-J, Marguerie G, Ginsberg MH. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen γ chain peptides share a common binding site on platelets. J Biol Chem 1987; 262: 947-50.
• 47 Chen CS, Hawiger J. Reactivity of synthetic peptide analogs of adhesive proteins in regard to the interaction of human endothelial cells with extracellular matrix. Blood 1991; 77: 2200-06.
• 48 Languino LR, Colella S, Zanetti A, Andrieux A, Ryckewaert JJ, Charon MH, Marchisio PC, Plow EF, Ginsberg MH, Marguerie G, Dejana E. Fibrinogen-endothelial cell interaction in vitro: a pathway mediated by an arg-gly-asp recognition specificity. Blood 1989; 73: 734-42.
• 49 Dejana E, Colella S, Languino LR, Balconi G, Cobascio GC, Marchisio PC. Fibrinogen induces adhesion, spreading, and microfilament organization of human endothelial cells in vitro. J Cell Biol 1987; 104: 1403-11.
• 50 Smith RA, Mosesson MW, Rooney MM, Lord ST, Daniels AU, Gartner TK. The role of putative fibrinogen Aα-, Bβ-, and γA-chain integrin binding sites in endothelial cell-mediated clot retraction. J Biol Chem 1997; 272: 22080-5.
• 51 Bunce LA, Sporn LA, Francis CW. Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the β chain. J Clin Invest 1992; 89: 842-50.
• 52 Tang L, Ugarova TP, Plow EF, Eaton JW. Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest 1996; 97: 1329-34.